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Introduction
Patulous Eustachian tube (PET) is a pathologic state char-
acterized by symptoms of aural fullness, autophony, and the 
hearing of physiologic breathing sounds, which was first de-
scribed in the late 1800s by Schwartze [1] and Jago [2]. The 
Eustachian tube (ET) links the middle ear to the nasopharynx, 
which is usually closed at rest and transiently opens during 
normal swallowing. However, abnormal persistent opening of 
the valve at rest leads to symptoms of PET [3].
Most cases subside spontaneously, but there are some in-
tractable cases that require surgical procedures. Surgical treat-
ments can be classified into three categories: 1) narrowing of 
the lumen of the ET by injecting a bulky agent, 2) surgical li-
gation of the ET orifice, and 3) plugging of the lumen with 
various materials [4].
Surgical treatments are ultimately undertaken to obstruct 
the ET lumen. Trials to obstruct the ET lumen have been con-
ducted by various means, such an indwelling catheter [5], a 
silicone plug [6], and cartilage block [7], in addition to inject-
ing small pieces of cartilage [8]. We modified the tragal carti-
lage plugging method, which was first reported by Kobayashi 
[7]. Our method can eliminate the risk of foreign body, while 
being considered more physiologic as it can reduce damage to 
Eustachian valve. Here, we evaluated the feasibility of modi-
fied tragal cartilage chip insertion technique via transcanal ap-
proach for treatment of PET.
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Background and Objectives: Patulous Eustachian tube (PET) causes troublesome autoph-
ony. We treated PET using tragal cartilage chip insertion to fill in the concavity within the 
tubal valve and evaluated the feasibility of this method. Subjects and Methods: This study 
used a prospective design. Eleven patients with PET disorder were included. Tragal carti-
lage chip insertion via a transcanal approach into the Eustachian tube (ET) was performed 
in 14 ears of those patients. They were followed-up for at least 12 months after surgery and 
were evaluated by symptom questionnaire scores. Results: The average follow-up was 16.4 
months. Thirteen of fourteen ears received immediate complete relief of autophony symp-
toms. Autophony symptoms at the last follow-up were as follows: four ears (28.6%) had 
complete relief; five ears (35.7%) showed satisfactory improvement; four ears (28.6%) 
showed significant but unsatisfactory improvement; and one ear (7.1%) was unchanged. The 
PET symptom questionnaire in the affected ears showed a significant reduction in autopho-
ny (p=0.047) and improvement in breathing sound conduction (p=0.047). There were no 
complications such as otitis media or occlusion symptom. Conclusions: Transtympanic car-
tilage chip insertion into the ET provides a safe and accessible surgical option for the treat-
ment of PET. J Audiol Otol 2018;22(3):154-159
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Subjects and Methods
Patient and outcome measurement 
This study used a prospective design. We included 14 ears 
from 11 patients who were diagnosed with PET under previ-
ously established diagnostic criteria (Table 1) [9]. All the pa-
tients were intractable to conservative therapy or ventilation 
tube insertion for more than one year.
Pure tone audiometry, a PET symptom questionnaire sur-
vey which was rated on a scale of zero to ten, and autophony 
symptom score (Table 2) [9] were evaluated preoperatively, at 
1 month after surgery (immediate follow-up), and during last 
follow-up visit (>12 months). The Institutional Review Board 
of the authors’ institution approved this study (IRB No. 4- 
2017-1184). Informed consent was obtained from each subject.
Statistical analysis
Preoperative and postoperative hearing thresholds were ana-
lyzed by nonparametric Wilcoxon signed-rank test, while PET 
symptom questionnaires before surgery, at immediate follow-
up, and at last follow-up were analyzed with nonparametric 
Friedman test using IBM SPSS 23 (IBM Corp., Armonk, NY, 
USA).
Surgical technique 
All surgeries were performed under local anesthesia. All 
surgeries were performed using microscope, except for the last 
one case, which used endoscope. Since endoscopic approach 
offered clearer and more magnified view of ET orifice com-
pared to microscopic approach, it was thought to be more suit-
able than microscopic approach for manipulating ET. Howev-
er, due to the lack of experience with endoscopic ear surgery, 
microscopic approaches were performed in the early period. 
The patient was placed in the supine position, and the head 
was rotated to the opposite side. The ear was prepared and 
draped in a sterile fashion. Injection with 1% xylocaine and 
1:100,000 epinephrine was administered into the external au-
ditory canal. Myringotomy was performed at the anteriosupe-
rior aspect of the tympanic membrane. After myringotomy, 
ET was identified and probed. Bleeding was controlled with 
cotton soaked in epinephrine.
 Tragal cartilage was then harvested in the largest possible 
quantity, preserving a width of 2-3 mm in the cartilage rim 
to maintain the shape of the cartilage. From the harvested car-
tilage, a long and thin piece of cartilage (up to 15 mm) was cut 
diagonally in order to make it as long as possible, and two 
smaller ones (7-8 mm) were also created. There might be 
small variations in length and shape according to patients, as 
the ET structure slightly differs among patients. Perichondrium 
was also harvested. Tragal cartilages were inserted into ET ori-
fice through myringotomy site. First, the longest piece of car-
tilage was inserted and reached the isthmus to obstruct it par-
tially. Next, the smaller pieces were inserted on both sides of 
the longest to obstruct ET, as well as for reinforcement. The 
inserted pieces of cartilage were reinforced with perichondri-
um, if necessary. Finally, a paper patch was applied to myr-
ingotomy site (Fig. 1, Supplementary Video 1 in the online-
only Data Supplement).
Table 1. PET diagnostic criteria
I. Clear symptoms of autophony made better by lying down without any symptomatic evidence of superior canal dehiscence 
(which can cause similar symptoms). Most also had aural fullness or a sensation of a plugged ear.
II. All patients recognized the sense of autophony caused by placing a finger in the ear canal to evoke the occlusion effect 
while they spoke. This reproduced their own autophony when their PET was most active. The occlusion effect enhances the 
low frequencies and bone conduction thresholds.
III. All patients’ symptoms were made better or completely alleviated by pressure on the neck on the side of the affected ear, 
which will affect ET transmitted vibrations.
IV. All patients’ symptoms were substantially relieved by mass loading of their tympanic membrane, usually over a single more 
flaccid segment, but sometimes both anterior and posterior tympanic membrane flaccid segments.
PET: patulous Eustachian tube, ET: Eustachian tube
Table 2. Patient telephone PET questionnaire and autophony symp-
tom score
Patient telephone PET questionnaire
1.  When I talk I hear my voice echoing in my ear 
(voice echoing)
2.  When I breathe I can hear my breathing in my ear 
(breathing sound)
3. My ear feels plugged and full (aural fullness)
4.  When my voice is echoing in my ear, environmental 
sounds are too loud or bothersome around me  
(hyperacusis)
Autophony symptom score
1. Complete relief
2. Significant improvement, satisfied
3. Significant improvement, dissatisfied
4. Unchanged
5. Worse
PET: patulous Eustachian tube
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Results
Fourteen ears of eleven patients were included in this study. 
The average age of the patients was 40.8 years, and there 
were two males and nine females. The average observation 
period was 16.4 months, and no complications were observed. 
The preoperative and postoperative average pure tone audiom-
etry did not show a statistically significant difference, at 20.5 dB 
and 21.1 dB, respectively (p=0.761). The chief preoperative 
complaint was voice echoing, followed by breathing sounds 
and a sense of “shivering” in the tympanic membrane. There 
were no complications such as otitis media or occlusion symp-
toms (Table 3). 
In the PET symptom questionnaire, voice echoing which is 
associated with autophony and breathing sounds were im-
proved (Fig. 2).
Regarding the autophony symptom score in the immediate 
postoperative period, 92.9% of cases showed complete remis-
sion; however, over time the symptom tended to re-appear. At 
the final visit, 64.3% of operated ears maintained a satisfacto-
ry result (Table 4, Fig. 3).
Discussion
The optimal treatment for PET has not been established 
clearly, and depends on the severity of the symptoms [6]. Con-
servative methods are usually recommended, such as suffi-
cient hydration, weight gain, saline nasal irrigation, and reas-
surance [4]. Some medications, including anxiolytics, Chinese 
herbal medicines, sympathomimetic agents [6], nasal steroid 
sprays, estrogen nasal solution, and topical irritants to induce 
mucosal edema [4], are helpful. 
However, surgical methods are required in some intracta-
A
B
C
Fig. 1. A: Autologous tragal cartilage 
was harvested, preserving a width 
of 2-3 mm in the cartilage rim. B: A 
long and thin piece of cartilage (15 
mm) was cut diagonally in order to 
make it as long as possible, and two 
smaller ones (7-8 mm) were also 
created. C: The three cartilage piec-
es were inserted through the myrin-
gotomy site. First, the longest piece 
was inserted and reached the isth-
mus to obstruct it partially. Next, the 
smaller pieces were inserted on both 
sides of the longest to reinforce it.
Table 3. Patient demographics
Patients (n) 11
Gender (male:female) 2:9
Ear (right:left) 6:8
Mean age (years) 40.8±25.38
Mean follow-up period (months) 16.4
Preoperative hearing threshold (dB) 20.5±18.2
Postoperative hearing threshold (dB) 21.1±17.0
Main complaint (%)
Voice echoing 8/11 (72.7)
Breathing sound 7/11 (63.6)
Sense of “shivering” of tympanic membrane 1/11 (9.1)
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ble and persistent cases. Physiologically, closure of the ET is 
maintained by the mucosal valve of the cartilaginous portion, 
which is approximately 5 mm in length and is located about 
10 mm distal to the tube from the torus tubarius [3]. Different 
surgical trials have been conducted aiming to narrow the lu-
men of ET, with varying success rates (Table 5) [5,10-17].
Fig. 2. Postoperative PET symptom 
questionnaire; voice echoing which 
is associated with autophony and 
breathing sounds were improved 
significantly, but aural fullness and 
hyperacusis were not. PET: patulous 
Eustachian tube.
Table 4. Postoperative autophony symptom score
Symptom score Immediate follow-up (%) Last follow-up (%)
1. Complete relief 92.9 28.6
2. Significant improvement, satisfied 0.0 35.7
3. Significant improvement, dissatisfied 7.1 28.6
4. Unchanged 0.0 7.1
5. Worse 0.0 0.0
Fig. 3. Postoperative autophony 
symptom score at the immediate 
postoperative period and last visit; 
symptoms disappeared in most of 
the patients at the immediate post-
operative period; however, over 
time, the symptoms re-appeared in 
some patients.
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Previously, Kobayashi [7] tried to treat PET using the trans-
tympanic cartilage insertion method. However, they changed 
the plugging material to tailored silicon tube. The average 
length of ET from middle ear orifice to nasopharyngeal orifice 
was about 35 mm, and its isthmus was about 12 mm distance 
from middle ear orifice. Therefore, they thought it was diffi-
cult to completely obstruct or probe the valve portion of ET. 
Thus, they designed a 22- to 25-mm-long silicon tube and 
reported good results [6]. After modifying the shape of this 
silicon tube, they recently reported that success rate of these 
old and new type silicon tubes for PET was 83.0%, based on 
evaluation of 252 ears from 191 patients [18]. Despite these 
favorable results, there are still some limitations in this silicon 
tube insertion technique: first, it may cause a foreign body re-
action in the tissue; second, normal bony portion of ET and 
the narrow isthmus structure could be injured when the silicon 
tube passes through them; and lastly, otitis media with effusion 
may occur if ET is obstructed completely with a silicon tube.
If we can use cartilage chip more efficiently and firmly, we 
can achieve more favorable results while reducing the risk of 
foreign body reaction, maintaining physiologic function such 
as middle ear gas exchange and clearing of middle ear secre-
tions, and preventing the possibility of middle ear effusion or 
otitis media.
Our modified transtympanic cartilage insertion technique 
is different from the original technique used by Kobayashi 
[7]. We used longer cartilage chip which can reach ET isth-
mus, even though it cannot pass through the isthmus. We also 
used two more cartilage chips and perichondrium to reinforce 
the first cartilage chip, and to reduce the recurrence of symp-
toms resulting from tissue absorption. 
Although our technique neither crosses the isthmus nor 
completely closes the valve, it can sufficiently obstruct the 
isthmus. More than 92% of examined ears showed complete 
symptom relief immediately, and this was the evidence of 
sufficient obstruction. Cartilage can reach and obstruct the 
isthmus (Fig. 1). During more than 12 months of follow-up, 
two-thirds of the patients maintained their improvement, and 
this was similar to the results from other previous reports, 
some of which used silicone tubes (Table 5). We performed 
revision surgery, of which the result was not included in this 
study, in one patient who had no improvement in symptoms 
after eight months since first surgery, and found that the previ-
ously inserted cartilage was not absorbed. In this respect, it is 
supposed that the absorption is slight and the effect of inser-
tion persists for a long time.
This type of insertion has some benefits compared with sili-
con tube insertion that crosses the isthmus. First, this proce-
dure does not involve complete passage through the valve, so 
it can reduce the risk of injury to structures surrounding the 
valve and possible complications. Despite the lack of complete 
passage through the valve, the symptoms were improved sig-
nificantly. Second, autologous tragal cartilage is used to reduce 
the risk of a foreign body reaction compared with the method 
that uses a foreign silicon tube. Third, the risk of otitis media 
resulting from complete closure in other previously reported 
methods is reduced. Fourth, our technique is easier than oth-
er previously reported methods. It is not necessary for the in-
sertion to be deep enough to pass completely through the 
valve. Also, tympanomeatal flap elevation and myringoplas-
ty need not be performed to facilitate the handling of inserted 
material. Finally, the use of autologous cartilage requires no 
additional approval from the Food and Drug Administration 
(FDA), as well as no additional cost for buying the material. 
At the last follow-up visit in some patients, postoperative 
autophony symptom scores were slightly higher than those 
at the immediate follow-up visit. These patients with recurred 
symptoms had surgery in early period. During early period, 
we did not obstruct the isthmus completely to reduce the risk 
of otitis media, and we believe this gap could have induced 
Table 5. Methods used to treat patulous Eustachian tube
Study Method Result
Pulec [10] Polytetrafluoroethylene (Teflon) paste injection 
anterior to ET orifice
Symptom improvement in 73% (19/26)
of patients
Stroud, et al. [11] Replacement of tensor veli palatini muscle Symptom improvement in 90% (9/10)
of patients
Bluestone and Cantekin [5] ET and ventilator tube insertion Symptom improvement in four patients
Chen and Luxford [12]
Endo, et al. [13]
Ventilator tube insertion
Effective in 70% (9/13) of patients
Effective in 90.9% (10/11) of patients
Doherty and Slattery [14] Autologous fat graft via the intranasal approach Symptom improvement in two patients
Takano, et al. [15] Closure of the nasopharyngeal aspect 
of the ET
Symptom improvement in 60% (6/10)
of patients
Kong, et al. [16] and Oh, et al. [17] Calcium hydroxyapatite injection Symptom improvement in three patients
ET: Eustachian tube
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absorption of inserted cartilage and recurrence of symptoms. 
However, we later inserted cartilage to completely obstruct 
the isthmus, considering slight absorption of cartilage with 
passage of time.
Nevertheless, voice echoing, which is associated with auto-
phony, was improved significantly at the immediate and final 
follow-up visits. Based on these results, we determined that 
some symptoms that are related to autophony seem to re-ap-
pear, although the severity of the symptoms seems to be im-
proved.
In our method, once myringotomy and ET orifice probing is 
performed, only the trimmed cartilage needs to be inserted 
into the orifice, which is then obstructed with perichondrium. 
Due to the ease of handling, the estimated time of surgery is 
short—approximately 30 minutes—and the surgery can be 
completed under local anesthesia.
In conclusion, transtympanic cartilage chip insertion into 
the ET via the transcanal anterior superior myringotomy 
technique represents a safe and accessible surgical option for 
the treatment of PET and provides a reliable and satisfactory 
outcome for PET patients.
Supplementary Video Legend
Video 1. Left endoscopic trans-tympanic cartilage chip in-
sertion.
Supplementary Materials
The online-only Data Supplement is available with this ar-
ticle at https://doi.org/10.7874/jao.2018.00017.
Acknowledgments
This research was supported by a grant of the Yonsei University 
College of Medicine (6-2016-0084).
The authors would like to thank Dong-Su Jang, MFA (Medical Illus-
trator, Medical Research Support Section, Yonsei University College of 
Medicine, Seoul, Korea) for his help with the illustrations. 
Conflicts of interest
The authors have no financial conflicts of interest.
REFERENCES
1)	 Schwartze H. Respiratorische bewegung des trommelfelles. Arch 
Ohrenheilkd 1864;1:139.
2)	 Jago J. The Eustachian Tube, when and how is it opened? J Anat 
Physiol 1869;3(Pt 2):341-8.
3)	 Poe DS. Diagnosis and management of the patulous eustachian tube. 
Otol Neurotol 2007;28:668-77.
4)	 Grimmer JF, Poe DS. Update on eustachian tube dysfunction and the 
patulous eustachian tube. Curr Opin Otolaryngol Head Neck Surg 
2005;13:277-82.
5)	 Bluestone CD, Cantekin EI. “How I do it”--otology and neurotolo-
gy. A specific issue and its solution. Management of the patulous 
Eustachian tube. Laryngoscope 1981;91:149-52.
6)	 Sato T, Kawase T, Yano H, Suetake M, Kobayashi T. Trans-tympan-
ic silicone plug insertion for chronic patulous Eustachian tube. Acta 
Otolaryngol 2005;125:1158-63.
7)	 Kobayashi T. Diagnosis and treatment of patulous eustachian tube. 
Pract Otol (Kyoto) 2000;93:897-907.
8)	 Oh SJ, Lee IW, Goh EK, Kong SK. Endoscopic autologous cartilage 
injection for the patulous eustachian tube. Am J Otolaryngol 2016;37: 
78-82. 
9)	 Brace MD, Horwich P, Kirkpatrick D, Bance M. Tympanic mem-
brane manipulation to treat symptoms of patulous eustachian tube. 
Otol Neurotol 2014;35:1201-6.
10)	Pulec JL. Abnormally patent eustachian tubes: treatment with injec-
tion of polytetrafluoroethylene (Teflon) paste. Laryngoscope 1967; 
77:1543-54.
11)	Stroud MH, Spector GJ, Maisel RH. Patulous eustachian tube syn-
drome. Preliminary report of the use of the tensor veli palatini trans-
position procedure. Arch Otolaryngol 1974;99:419-21.
12)	Chen DA, Luxford WM. Myringotomy and tube for relief of patu-
lous eustachian tube symptoms. Am J Otol 1990;11:272-3. 
13)	Endo S, Mizuta K, Takahashi G, Nakanishi H, Yamatodani T, Misa-
wa K, et al. The effect of ventilation tube insertion or trans-tympanic 
silicone plug insertion on a patulous Eustachian tube. Acta Otolar-
yngol 2016;136:551-5. 
14)	Doherty JK, Slattery WH 3rd. Autologous fat grafting for the refrac-
tory patulous eustachian tube. Otolaryngol Head Neck Surg 2003; 
128:88-91.
15)	Takano A, Takahashi H, Hatachi K, Yoshida H, Kaieda S, Adachi T, 
et al. Ligation of eustachian tube for intractable patulous eustachian 
tube: a preliminary report. Eur Arch Otorhinolaryngol 2007;264: 
353-7. 
16)	Kong SK, Lee IW, Goh EK, Park SH. Autologous cartilage injection 
for the patulous eustachian tube. Am J Otolaryngol 2011;32:346-8. 
17)	Oh SJ, Kang DW, Goh EK, Kong SK. Calcium hydroxylapatite in-
jection for the patulous Eustachian tube. Am J Otolaryngol 2014;35: 
443-4.
18)	Kikuchi T, Ikeda R, Oshima H, Takata I, Kawase T, Oshima T, et al. 
Effectiveness of Kobayashi plug for 252 ears with chronic patulous 
Eustachian tube. Acta Otolaryngol 2017;137:253-8.
